We report the identification and nucleotide sequence analysis of a cryptic plasmid pMIDG2830 from the Gram-negative bacterium Neisseria flavescens. The largest open reading frame encodes a protein similar to the replication protein, RepA, found in pAB49 from Acinetobacter baumannii and pNI10 from Pseudomonas. Modified by the incorporation of a kanamycin resistance cassette, the plasmid can be stably maintained in Escherichia coli and Neisseria meningitidis, and can be used as a shuttle plasmid in meningococcal research.
Introduction
Naturally occurring plasmids have been identified in the genus Neisseria, in particular in the pathogenic species Neisseria gonorrhoeae [1] . Several different types of plasmid have been isolated: beta-lactamase; encoding (often multiple) resistance determinants for other antibiotics and cryptic [1] . Variants of the beta-lactamase plasmid have a broad host range, replicating in the pathogenic Neisseria and several commensal Neisseria [2, 3] as well as other organisms including Escherichia coli, Salmonella enterica, Haemophilus influenzae and Haemophilus ducreyi [4] [5] [6] [7] [8] . Multi-resistance plasmids have been isolated from several commensal Neisseria species [9, 10] . These plasmids -the enteric plasmid RSF1010, an IncQ (P-4) plasmid and the R plasmid pFM739 -variously encode streptomycin, sulfonamide, ampicillin, sulfamethoxazole-trimethoprim and pencillin resistance. A 4.2 kb cryptic plasmid is found in almost all isolates of N. gonorrhoeae [1] and has also been identified in meningococci and Neisseria lactamica [11] .
We now report the characterisation of a smaller cryptic plasmid unlike any previously described, from the commensal Neisseria flavescens. This plasmid can be transferred to Neisseria meningitidis in the laboratory, demonstrating both value as a tool in genetic research and the potential for such elements to contribute to meningococcal diversity. The E. coli strain used in this study was TOP10 [12] which was maintained on Luria-Bertani medium (Oxoid) with appropriate antibiotics. For both E. coli and neisserial strains, the following antibiotics were used at the indicated concentrations: ampicillin, 100 lg ml À1 and kanamycin, 75 lg ml À1 .
Materials and methods

Bacterial strains and growth conditions
Recombinant DNA and other methods
Standard methods were used for DNA preparation, restriction enzyme analysis, cloning, PCR and sequencing [13] . Transformations were carried out using a heat shock protocol for chemically competent E. coli TOP10 as described by the manufacturer (Invitrogen).
Cloning and sequencing of the plasmid pMIDG2830
The plasmid, pMIDG2830 ( Fig. 1(a) ), was linearised using EcoRI and cloned into the pUC-based plasmid pZerO-2 (Invitrogen) to facilitate sequencing. The universal M13 forward and reverse primers were used for the initial sequencing. Based on the sequences obtained, 18-to 20-mer oligonucleotide primers were synthesised and used to ''walk'' along the pMIDG2830 sequence. DNA sequencing reactions were performed using the BigDye terminator cycle sequencing kit (Perkin-Elmer). Sequence from the plasmid was used to interrogate the non-redundant public DNA and protein databases using the BLAST set of similarity search programs.
Southern blotting
Southern blots were performed using the plasmid labelled with digoxigenin (DIG)-11-dUTP by random priming with the DIG DNA Labelling and Detection Kit according to the manufacturerÕs instructions (Roche Diagnostics).
Modification of pMIDG2830
A fragment containing the aphA-3 gene (encoding an aminoglycoside modifying enzyme that inactivates kanamycin) was inserted into pMIDG2830 ( Fig. 1(a) ) to act as a selectable marker. The ClaI site was selected, as it is a unique restriction site, not located in either open reading frame. Plasmid from two selected colonies, one with the kanamycin cassette in each orientation as demonstrated by restriction digestion, was purified using a Qiagen midi kit. The constructs were called pMIDG-2830.2 and pMIDG2830.3 ( Fig. 1(b) and (c)) defined by the transcriptional direction of the aphA-3 gene opposite, or the same as the ORFs in pMIDG2830.
A fragment containing the strong meningococcal ner promoter, and the meningococcal outer membrane protein gene nspA, was amplified from pMIDG201::nspA [14] using the oligonucleotide primers 401US (5 0 GCA-GTCTCTCGAGCTCAAG 3 0 ) and MIDG200DS (5 0 GGCTTTACACTTTATGCTTCCG 3 0 ). This fragment was then cloned into the single BglI site of pMIDG-2830.2 -not located in either open reading frame.
Meningococcal transformation
Meningococcal strains (1 · 10 8 cfu ml À1 ) were incubated with pMIDG2830.2 and pMIDG2830.3 plasmid DNA (1 lg ml À1 final concentration) in Mueller-Hinton broth supplemented with 1% Vitox. Following 4-5 h incubation at 37°C 5% CO 2 the transformation mix was plated onto GC agar plates containing 75 lg ml À1 kanamycin. Plasmid DNA was isolated from N. meningitidis and analysis by restriction digest confirmed the presence of the pMIDG2830 derivatives.
Stability
Plasmid stability was evaluated in the serogroup B strain N. meningitidis MC58 by isolating DNA from plate grown meningococci containing pMIDG2830 and its derivatives during 10 sub-cultures in the absence and presence of antibiotic selective pressure. Plasmid DNA was purified from individual transformants using a Qiaprep Spin mini kit (Qiagen) and was subsequently digested with restriction endonucleases. Digested vectors were subjected to electrophoresis in 1% agarose gels, and the restriction pattern was compared to that generated by digestion of the original vector with the same enzymes.
Construction of a N. meningitidis 608B nspA mutant
The coding region of meningococcal nspA, cloned in to pGEMT, was interrupted by insertion of a chloramphenicol resistance cassette (Cm r ), originally from the Staphylococcus aureus plasmid pC194, at the unique SalI site located 334 bp downstream from the nspA initiation codon. N. meningitidis 608B was transformed with linearised DNA from this plasmid to create an nspA-null knock-out mutant. Allelic replacement of the wild-type gene was confirmed by PCR and Western blot analysis.
Western blot analysis
Bacterial colonies were harvested into phosphate-buffered saline (PBS) from overnight GC plate cultures, washed, and the pellet resuspended in reducing buffer [13] . Equal amounts of protein were subjected to SDS-PAGE and electro-transferred on to nitrocellulose membranes for Western blotting [13] . The primary antibody was anti-NspA MAb Me-23 [14] . The secondary antibody was anti-mouse IgG + IgM conjugated to alkaline phosphatase (Sigma). The signal was detected after incubation in 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium according to the manufacturerÕs instructions (Sigma). (Fig. 2) . pMIDG2830 consists of 2073 bp and has a G + C content of 42% (570 T, 372 C, 632 A, 499 G) lower than the sequenced neisserial genomes (52%). This difference suggests the possibility that the plasmid may have been acquired from a nonneisserial species by horizontal transfer, although its small size makes sequence comparisons of this sort highly speculative. The sequence has been submitted to GenBank (Accession No. AY174058). Database searches carried out in GenBank using the BLASTN program (http://www.ncbi.nlm.nih.gov) revealed no significant homology with any other DNA sequence. The neisserial uptake sequence was not present in the plasmid.
Open reading frames of pMIDG2830 and homology with other sequences
Analysis of the deduced amino acid (aa) sequence of pMIDG2830 revealed two open reading frames (ORFs), which have the same transcription direction on the plasmid (Fig. 1) . The 446 aa putative product of ORF1 shows sequence similarity to the replication protein (RepA) from two Gram-negative cryptic plasmids: pAB49 from Acinetobacter baumannii (36% identity over 292 aa), and pNI10 from Pseudomonas fulva (34% identity over 323 aa). There are also amino acid similarities between the putative ORF1 product and proteins involved in replication of the Gram-positive plasmids pBC1 from Bacillus coagulans and pSH1452 from B. pumilus (Fig. 3) . This suggests that ORF1 encodes a protein involved in pMIDG2830 replication. The 102 aa putative product of ORF 2 could not be assigned a putative function.
Distribution of pMIDG2830 in neisserial strains
The presence of pMIDG2830 in other neisserial species was investigated by Southern blot analysis. A variety of gonococcal strains were examined, five of which were known to contain plasmids. Three further N. flavescens strains were also examined. N. flavescens 2017 contained a plasmid subsequently shown by sequencing to be identical to pMIDG2830. No plasmid was present in strains 2831 and 2832. A pMIDG2830 probe failed to hybridise to DNA from any of the following Neisseria species (number of strains) tested: N. lactamica (4) . N. cinerea (3), N. flava (1), N. subflava (1) , N. sicca (1) , N. polysacchareae (1) , N. mucosa (1), N. meningitidis (4) and N. gonorrhoeae (7) . This cryptic plasmid may be unique to N. flavescens.
Replication of pMIDG2830 derivatives in N. meningitidis
The modified plasmids pMIDG2830.2 and pMIDG-2830.3 were successfully transformed into N. meningitidis, and replicated stably in this species over many generations (see 2.7). Transformation frequencies in the serogroup B strain MC58, determined in each case on five occasions, were 5.82 · 10 À7 ± SD 2.52 · 10
À7
and 2.75 · 10 À7 ± SD 2.62 · s10 À7 , respectively. Efficiency of transformation was approximately 50 transformants per lg DNA. A variety of other meningococcal strains were also tested for uptake of the plasmids. They were successfully transferred into two serogroup C strains (L93/4286 and 90/1831) and two other serogroup B strains (NGP165 and NGH15), but repeated attempts to transfer them into two serogroup A strains (Z2491 and F6124) have proved unsuccessful. Interestingly, to date no plasmid has been described that replicates successfully in serogroup A.
In an attempt to increase the recovery of plasmid-containing mutants, repeated attempts were made to transfer these plasmids from E. coli into Neisseria using a standard conjugation protocol [14] . These were uniformly unsuccessful -perhaps unsurprising for such small plasmids, lacking any recognisable mob genes.
Various native neisserial plasmids have been modified as genetic tools for Neisseria research. These plasmids have been used to investigate mechanisms of plasmid DNA uptake during transformation [15] and conjugation [16] , the expression of genes in neisserial species [17, 18] , in the construction of suicide vectors [19] , as vectors for transposon mutagenesis [20] and as E. coli to Neisseria shuttle vectors [20] [21] [22] . However, these have mainly been developed for use in N. gonorrhoeae, with only a few plasmids such as pMGC10 [20] , pHT128 143
LGHLEIEQWKLIRQAGLRAKVLDLAESNGGWVAIQHLLRGLLNGGLSMTHSNQDLTPEDEGLPIFVSDEQEALPLPGFVTRETHRSSKAVIRQKIATAMT 451 pBC1 [18] and pFP10 [23] [24] replicating and being maintained stably in N. meningitidis. To explore the potential of pMIDG2830 as a shuttle vector, the meningococcal gene nspA -under the control of the strong ner promoter -was amplified from pMIDG201::nspA [14] and cloned into pMIDG2830.2. This plasmid was then used to successfully complement a N. meningitidis nspA mutant strain (Fig. 4) . pMIDG2830 has useful potential as an E. coli to N. meningitidis shuttle vector.
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